Literature DB >> 31128501

Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure.

Alan Shafer1, Federico Dazzi2.   

Abstract

A meta-analysis of the results of 45 factor analyses (n = 22,812) of the Positive and Negative Syndrome Scale (PANSS) was conducted. Meta-analyses of the PANSS was conducted using both a co-occurrence similarity matrix and reproduced correlations. Both methods produced similar results. Five factors (Positive Symptoms, Negative Symptoms, Disorganization, Affect and Resistance) emerged clearly across both analyses. The factors and the items defining them were Positive Symptoms (P1 Delusions, G9 Unusual thought content, P3 Hallucinatory behavior, P6 Suspiciousness and persecution, P5 Grandiosity), Negative Symptoms (N2 Emotional withdrawal, N1 Blunted affect, N4 Passive apathetic social withdrawal, N6 Lack of spontaneity, N3 Poor rapport, G7 Motor retardation, G16 Active social avoidance), Disorganization often termed Cognitive (P2 Conceptual disorganization, G11 Poor attention, N5 Difficulty in abstract thinking, G13 Disturbance of volition, N7 Stereotyped thinking, G5 Mannerisms/posturing, G15 Preoccupation, G10 Disorientation), Affect often termed Depression-Anxiety (G2 Anxiety, G6 Depression, G3 Guilt feelings, G4 Tension, G1 Somatic concern) and a small fifth factor that might be characterized as Resistance or Excitement/Activity (P7 Hostility, G14 Poor impulse control, P4 Excitement, G8 Uncooperativeness). Items G1, G4, G10, P5, G5, G15 may not be core items for the PANSS factors and G12 lack of judgment is not a core item. Results of the PANSS meta-analyses were relatively similar to those for meta-analysis of both the BPRS and BPRS-E all of which contain the original 18 BPRS items. The PANSS is distinguished by a much larger number of items to clearly define and measure Negative Symptoms as well as a sufficient number of items to much more clearly identify a Disorganization factor than the BPRS or BPRS-E.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31128501     DOI: 10.1016/j.jpsychires.2019.05.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  17 in total

1.  Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial.

Authors:  Leandro da Costa Lane Valiengo; Stephan Goerigk; Pedro Caldana Gordon; Frank Padberg; Mauricio Henriques Serpa; Stephanie Koebe; Leonardo Afonso Dos Santos; Roger Alberto Marcos Lovera; Juliana Barbosa de Carvalho; Martinus van de Bilt; Acioly L T Lacerda; Helio Elkis; Wagner Farid Gattaz; Andre R Brunoni
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

2.  Negative symptoms in first episode schizophrenia: treatment response across the 2-year follow-up of the "Parma Early Psychosis" program.

Authors:  Lorenzo Pelizza; Emanuela Leuci; Davide Maestri; Emanuela Quattrone; Silvia Azzali; Giuseppina Paulillo; Pietro Pellegrini
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-28       Impact factor: 5.270

3.  Hierarchical Symptom Components in Early Psychosis.

Authors:  Julia M Longenecker; Gretchen L Haas; Dean F Salisbury
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

4.  The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.

Authors:  Katarzyna Rek-Owodziń; Ernest Tyburski; Piotr Plichta; Katarzyna Waszczuk; Maksymilian Bielecki; Krzysztof Wietrzyński; Piotr Podwalski; Krzysztof Rudkowski; Anna Michalczyk; Tomasz Grąźlewski; Leszek Sagan; Jolanta Kucharska-Mazur; Jerzy Samochowiec; Monika Mak
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

5.  Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients.

Authors:  Katarzyna Waszczuk; Jolanta Kucharska-Mazur; Ernest Tyburski; Katarzyna Rek-Owodziń; Piotr Plichta; Krzysztof Rudkowski; Piotr Podwalski; Tomasz Grąźlewski; Monika Mak; Błażej Misiak; Anna Michalczyk; Maciej Tarnowski; Katarzyna Sielatycka; Angelika Szczęśniak; Karolina Łuczkowska; Barbara Dołęgowska; Marta Budkowska; Mariusz Z Ratajczak; Jerzy Samochowiec
Journal:  Int J Environ Res Public Health       Date:  2022-05-15       Impact factor: 4.614

6.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

7.  Case Report: Feasibility of a Novel Virtual Reality-Based Intervention for Patients With Schizophrenia.

Authors:  Edit Vass; Viktória Simon; Zita Fekete; Balázs Kis; Lajos Simon
Journal:  Front Psychol       Date:  2021-02-26

8.  DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia.

Authors:  Xiaofen Zong; Qinran Zhang; Changchun He; Xinyue Huang; Jiangbo Zhang; Gaohua Wang; Luxian Lv; Deen Sang; Xiufen Zou; Huafu Chen; Junjie Zheng; Maolin Hu
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

9.  Effective Connectivity of the Hippocampus Can Differentiate Patients with Schizophrenia from Healthy Controls: A Spectral DCM Approach.

Authors:  Lavinia Carmen Uscătescu; Lisa Kronbichler; Renate Stelzig-Schöler; Brandy-Gale Pearce; Sarah Said-Yürekli; Luise Antonia Reich; Stefanie Weber; Wolfgang Aichhorn; Martin Kronbichler
Journal:  Brain Topogr       Date:  2021-09-04       Impact factor: 3.020

10.  Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts.

Authors:  Bong Ju Lee; Sung-Wan Kim; Jung Jin Kim; Je-Chun Yu; Kyu Young Lee; Seung-Hee Won; Seung-Hwan Lee; Seung-Hyun Kim; Shi Hyun Kang; Euitae Kim; Kunhyung Kim; Yang Hong Piao; Young-Chul Chung
Journal:  Psychiatry Investig       Date:  2020-02-25       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.